Exosens has lifted its sales, margins and outlook for the first half of 2026, according to the company’s latest earnings call.

The revision was announced during the company’s Q2 2026 earnings call presentation. Exosens (EXSNY) reported its second-quarter results and updated its financial guidance for the first half of the year.